Dyskinesia after discountinuation of compound analgesic containing oxycodone.
D001241:Aspirin / Q000627:therapeutic use; D002110:Caffeine / Q000627:therapeutic use; D003061:Codeine / Q000031:analogs & derivatives*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008875:Middle Aged; D009069:Movement Disorders / Q000209:etiology*; D010098:Oxycodone / Q000009:adverse effects* / Q000627:therapeutic use; D010149:Postoperative Pain / Q000188:drug therapy; D010615:Phenacetin / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome
D004338:Drug Combinations; D002110:Caffeine; D010098:Oxycodone; D010615:Phenacetin; D001241:Aspirin; D003061:Codeine